Sanofi – Filings and Transcripts

NASDAQ: SNY
Share price (11/6/26): $47.04
Market cap (11/6/26): $115 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Registration of securities for employees

Third party tender offer – amended

Amendment to registration of securities for employees

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Holdings report

Latigo Biotherapeutics Inc.

Latigo Biotherapeutics Inc.

Attovia Therapeutics Inc.

News Filter

Q3 2026: Double-Digit Growth in Sales and Business EPS FY 2026: Guidance Upgraded

Breaks Ground on New State-Of-The-Art Insulin Manufacturing Facility in Germany

Sanofi and Regeneron Expand Global Alliance With Multiple Next-Generation, Long-Acting Immunology Antibodies

Sanofi and Cheplapharm to Create New Strategic Partnership in Mature Medicines

MenQuadfi Approved in the EU for Use in Infants From Age Six Weeks Against Invasive Meningococcal Disease

Proxies Filter

Annual report of proxy voting record

Annual report of proxy voting record

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Other Filter

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure